A Higher Frequency Administration of the Nontoxic Cycloartane-Type Triterpene Argentatin A Improved Its Anti-Tumor Activity
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Parthenium argentatum (Gray), commonly known as guayule, has been used to obtain natural rubber since the beginning of the 20th century. Additionally, the so called “resin” is a waste product derived from the industrial process. The cycloartane-type triterpene Argentatin A (AA) is one of the main constituents of the industrial waste resin. In this study we evaluated the AA anticancer activity both in vitro and in vivo in the HCT116 colon cancer cells. The apoptosis promotion of AA was assessed by the annexin V/propidium iodide (PI) assay. The senescence was evaluated for SA-β-galactosidase, and PCNA was used as a marker of proliferation. Its antitumor activity was evaluated using a xenograft mouse model. The results indicated that AA-induced apoptosis in HCT-116 cells and was positively stained for SA-β-galactosidase. In the xenografted mice test, the administration of AA at the dose of 250 mg/kg three times a week for 21 days reduced tumor growth by 78.1%. A comparable tumor reduction was achieved with cisplatin at the dose of 2 mg/kg administered three times a week for 21 days. However, nude mice treated with AA did not lose weight, as they did remarkably when treated with cisplatin. Furthermore, the animals treated with AA showed similar blood profiles as the healthy control group. These data indicate the low toxicity of AA compared to that shown by cisplatin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The activity of the argentatins against various colon cancer cell lines has been reported to range from 24 to 61 μM [19, 21].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“have been reported to reduce tumour growth in murine cancer models with less toxicity than cisplatin [18, 21].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We also found that argentatin A was more cytotoxic in the HCT‐116 and SW480 cell lines compared with that of a previous study [21], with an IC50 almost half of the reported 43.17 and 61.33 μM, respectively.”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · cited 1×
“Expression of p21 is usually linked to p53 and DNA injury [31], at this point the mechanism by which AA-treatment leads to expression of p21 remains unknown.”
BackgroundWestern blot: technique, theory, and trouble shooting
Yang, P.-C., & Mahmood, T. (2012) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.100998 · Cited by 1,421
Mechanisms and functions of cellular senescence
Herranz, N., & Gil, J. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95148 · Cited by 1,232 · cited 1×
“In addition, it has already been mentioned that cellular senescence is associated with higher β galactosidase (SA-β-gal) activity levels, and with the activation of several cell cycle arrest regulators, mainly p53-p21 and p16-Rb [29].”
BackgroundTherapy-induced senescence in cancer.
Ewald, J. A., Desotelle, J. A., Wilding, G., & Jarrard, D. F. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq364 · Cited by 824 · cited 2×
“However, although these approaches may lead to the disappearance of a solid tumor, they can also cause serious side effects in patients [33], thereby diminishing drug security.”
BackgroundNatural products in cancer chemotherapy: past, present and future
Mann, J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc723 · Cited by 684
Stress, cell senescence and organismal ageing
de Magalhães, J. P., & Passos, J. F. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.07.001 · Cited by 316 · cited 1×
“, p21 and p16), a diminished DNA replication capability, and a reduced level of PCNA contribute to cell senescence [22].”
Background
Research works printed but not linked: 1
- Rodriguez, 1970, Determinación de las estructuras de las argentatinas A,B y C del guayule, Rev. Latinoam. Química, 1, 24
Cited by
Dehghanizadeh, M., Mendoza Moreno, P., Sproul, E., Bayat, H., Quinn, J. C., & Brewer, C. E. (2021) · Industrial Crops and Products · doi:10.1016/j.indcrop.2021.113410 · Cited by 51
Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review
Fakhri, S., Moradi, S. Z., Ash-Rafzadeh, A., & Bishayee, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105961 · Cited by 39
LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer
Nie, X., Liu, H., Ye, W., Wei, X., Fan, L., Ma, H., Li, L., Xue, W., Qi, W., Wang, Y., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17164 · Cited by 27
Xu, Y.-M., Madasu, C., Liu, M. X., Wijeratne, E. M. K., Dierig, D., White, B., Molnár, I., & Gunatilaka, A. A. L. (2021) · ACS Omega · doi:10.1021/acsomega.1c01714 · Cited by 19
Dong, C., Ponciano, G., Huo, N., Gu, Y., Ilut, D. C., & McMahan, C. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01026-7 · Cited by 17
Metadata
- Authors
- Tavarez-Santamaría, Z., Jacobo-Herrera, N. J., Rocha-Zavaleta, L., Zentella-Dehesa, A., Couder-García, B. D. C., & Martínez-Vázquez, M.
- Affiliations
- Universidad Nacional Autónoma de México (MX)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Circuito Mario de la Cueva s/n, Ciudad Universitaria, C.P. Mexico City 04510, Mexico
- Unidad de Bioquímica. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Sección XVI, Mexico City 14000, Mexico
- Departamento de Productos Naturales. Instituto de Química, Universidad Nacional Autónoma de México, Mexico City, Circuito Exterior s/n, Ciudad Universitaria, Mexico City 04510, Mexico
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-04-14
- Volume
- 25
- Issue
- 8
- Pages
- 1780
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7221627
- OpenAlex
- W3017215849
- Cited by
- 22
- References
- 33
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 5 · 2020: 1
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejo Nacional de Ciencia y Tecnología
- Universidad Nacional Autónoma de México
- Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Phytochemical Studies and Bioactivities
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- guayule resin, colon cancer, HCT116 cells, apoptosis, cellular senescence, xenograft tumor growth, cisplatin comparison, dosing frequency, anticancer activity, low toxicity
- MeSH terms
- Animals, Antineoplastic Agents, beta-Galactosidase, Colonic Neoplasms, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Immunohistochemistry, Triterpenes, Molecular Structure, Biomarkers, Apoptosis, Xenograft Model Antitumor Assays, Cell Line, Tumor, Tumor Burden, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Higher Frequency Administration of the Nontoxic Cycloartane-Type Triterpene Argentatin A Improved Its Anti-Tumor Activity. https://app.cochat.ai/papers/10.3390/molecules25081780
- The paper
- Tavarez-Santamaría, Z., Jacobo-Herrera, N. J., Rocha-Zavaleta, L., Zentella-Dehesa, A., Couder-García, B. D. C., & Martínez-Vázquez, M. (2020). A Higher Frequency Administration of the Nontoxic Cycloartane-Type Triterpene Argentatin A Improved Its Anti-Tumor Activity. Molecules. https://doi.org/10.3390/molecules25081780
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.